The US stock market is facing a bumpy ride as it grapples with the persistent stress in the banking sector, compounded by the heightened fear over the US debt ceiling. The market turbulence is further fueled by concerns over high consumer inflation, which despite cooling off from its peak in June, remains above the Federal Reserve's target.
Given the uncertainty, it is crucial to monitor your portfolio's health. Therefore, Avid Bioservices, Inc. (CDMO), which is currently trading below its 50-day and 200-day moving averages, could be best avoided, and in this article, I will explain why.
